Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Strange

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Treatment of Alpha-1 Antitrypsin DeficiencyCharlie Strange, Tatsiana Beiko
Expert Opinion on Pharmacotherapy|November 9, 2017
A review of current and developing fixed-dose LABA/LAMA combinations for treating COPDChitra Lal, Charlie Strange
Expert Opinion on Pharmacotherapy|January 20, 2015
Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary diseaseChitra Lal, Charlie Strange
Chest|February 11, 2003
Chest ultrasound for "Dummies"Peter Doelken, Charlie Strange
International Journal of Chronic Obstructive Pulmonary Disease|January 25, 2017
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapyChitra Lal, Charlie Strange
Southern Medical Journal|May 17, 2018
Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United StatesSuchit Kumbhare, Charlie Strange
Respirology (Carlton, Vic.)|June 3, 2024
Winning the Tour de France with endobronchial valve therapy without pulmonary rehabilitationCharlie Strange, Melinda Talley
Annals of the American Thoracic Society|July 9, 2016
Reply: Asthma/COPD Overlap Syndrome and Medicare 30-Day ReadmissionsCharlie Strange, Suchit Kumbhare
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|May 4, 2011
Is systemic sclerosis interstitial lung disease slowly progressive?Chitra Lal, Charlie Strange
Expert Opinion on Pharmacotherapy|April 16, 2019
Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD)Chitra Lal, Charlie Strange
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Treatment of Alpha-1 Antitrypsin DeficiencyCharlie Strange, Tatsiana Beiko
Expert Opinion on Pharmacotherapy|November 9, 2017
A review of current and developing fixed-dose LABA/LAMA combinations for treating COPDChitra Lal, Charlie Strange
Expert Opinion on Pharmacotherapy|January 20, 2015
Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary diseaseChitra Lal, Charlie Strange
Chest|February 11, 2003
Chest ultrasound for "Dummies"Peter Doelken, Charlie Strange
International Journal of Chronic Obstructive Pulmonary Disease|January 25, 2017
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapyChitra Lal, Charlie Strange
Southern Medical Journal|May 17, 2018
Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United StatesSuchit Kumbhare, Charlie Strange
Respirology (Carlton, Vic.)|June 3, 2024
Winning the Tour de France with endobronchial valve therapy without pulmonary rehabilitationCharlie Strange, Melinda Talley
Annals of the American Thoracic Society|July 9, 2016
Reply: Asthma/COPD Overlap Syndrome and Medicare 30-Day ReadmissionsCharlie Strange, Suchit Kumbhare
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|May 4, 2011
Is systemic sclerosis interstitial lung disease slowly progressive?Chitra Lal, Charlie Strange
Expert Opinion on Pharmacotherapy|April 16, 2019
Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD)Chitra Lal, Charlie Strange
Pageof 20